Previous Article | Next Article 
Journal of Clinical Microbiology, February 2000, p. 635-638, Vol. 38, No. 2
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Serology of Culture-Confirmed Cases of Human Granulocytic
Ehrlichiosis
Maria E.
Aguero-Rosenfeld,1,*
Fatemeh
Kalantarpour,2
Mehdi
Baluch,1
Harold W.
Horowitz,2
Donna F.
McKenna,2
John T.
Raffalli,2
Tze-chen
Hsieh,3
Joseph
Wu,3
J. Stephen
Dumler,4 and
Gary P.
Wormser2
Department of
Pathology,1 Department of Medicine,
Division of Infectious Diseases,2 and
Department of Biochemistry and Molecular
Biology,3 New York Medical College, Westchester
Medical Center, Valhalla, New York, and Department of
Pathology, Johns Hopkins Medical Institutions, Baltimore,
Maryland4
Received 16 August 1999/Returned for modification 8 October
1999/Accepted 23 November 1999
We evaluated the antibody responses in the sera of 24 patients with
culture-confirmed human granulocytic ehrlichiosis (HGE). Antibody
titers were measured by an indirect immunofluorescent-antibody assay
(IFA) by using a local human isolate as the source of antigen. All
patients received appropriate antimicrobial treatment. One hundred five
serum specimens collected at baseline and at periodic intervals for up
to 14 months were included in the study. Seroconversion was observed in
21 of 23 patients (91.3%) from whom convalescent-phase sera were
obtained. Antibodies were first detected at an average of 11.5 days
after onset of symptoms. Peak titers (
2,560 for 71.4% of patients
and
640 for 95.2% of patients) were obtained an average of 14.7 days
after onset of symptoms. Eleven of 13 patients (84.6%) from whom sera
were collected between 6 and 10 months after onset of symptoms were
still seropositive, and sera from 5 of 10 (50%) patients tested
positive between 11 and 14 months after onset of symptoms. For a subset
of 71 serum specimens from 17 patients with culture-confirmed HGE also
tested by IFA by using either a human isolate from Wisconsin or an
Ehrlichia equi isolate from a horse, there was qualitative
agreement for 62 serum specimens (87.3%). Peak titers were higher,
however, with the local human HGE isolate, but the difference was not
statistically significant. In summary, most patients with
culture-confirmed HGE develop antibodies within 2 weeks of onset of
symptoms. Antibodies reach high titers during the first month and
remain detectable in about one-half of patients at 1 year after onset
of symptoms.
*
Corresponding author. Mailing address: Clinical
Laboratories Room 1J-11a, Westchester Medical Center, Valhalla,
NY 10505. Phone: (914) 493-7389. Fax: (914) 493-5742. E-mail:
maria_aguero-rosenfeld{at}nymc.edu.
Journal of Clinical Microbiology, February 2000, p. 635-638, Vol. 38, No. 2
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Krause, P. J., Wormser, G. P.
(2008). Nosocomial Transmission of Human Granulocytic Anaplasmosis?. JAMA
300: 2308-2309
[Full Text]
-
Alberti, A., Zobba, R., Chessa, B., Addis, M. F., Sparagano, O., Pinna Parpaglia, M. L., Cubeddu, T., Pintori, G., Pittau, M.
(2005). Equine and Canine Anaplasma phagocytophilum Strains Isolated on the Island of Sardinia (Italy) Are Phylogenetically Related to Pathogenic Strains from the United States. Appl. Environ. Microbiol.
71: 6418-6422
[Abstract]
[Full Text]
-
Arsenault, W. G., Messick, J. B.
(2005). Acute Granulocytic Ehrlichiosis in a Rottweiler. Journal of the American Animal Hospital Association
41: 323-326
[Abstract]
[Full Text]
-
Levin, M. L., Coble, D. J., Ross, D. E.
(2004). Reinfection with Anaplasma phagocytophilum in BALB/c Mice and Cross-Protection between Two Sympatric Isolates. Infect. Immun.
72: 4723-4730
[Abstract]
[Full Text]
-
Bayard-Mc Neeley, M, Bansal, A, Chowdhury, I, Girao, G, Small, C B, Seiter, K, Nelson, J, Liveris, D, Schwartz, I, Mc Neeley, D F, Wormser, G P, Aguero-Rosenfeld, M E
(2004). In vivo and in vitro studies on Anaplasma phagocytophilum infection of the myeloid cells of a patient with chronic myelogenous leukaemia and human granulocytic ehrlichiosis. J. Clin. Pathol.
57: 499-503
[Abstract]
[Full Text]
-
Massung, R. F., Slater, K. G.
(2003). Comparison of PCR Assays for Detection of the Agent of Human Granulocytic Ehrlichiosis, Anaplasma phagocytophilum. J. Clin. Microbiol.
41: 717-722
[Abstract]
[Full Text]
-
Lin, Q., Zhi, N., Ohashi, N., Horowitz, H. W., Aguero-Rosenfeld, M. E., Raffalli, J., Wormser, G. P., Rikihisa, Y.
(2002). Analysis of Sequences and Loci of p44 Homologs Expressed by Anaplasma phagocytophila in Acutely Infected Patients. J. Clin. Microbiol.
40: 2981-2988
[Abstract]
[Full Text]
-
Aguero-Rosenfeld, M. E., Donnarumma, L., Zentmaier, L., Jacob, J., Frey, M., Noto, R., Carbonaro, C. A., Wormser, G. P.
(2002). Seroprevalence of Antibodies That React with Anaplasma phagocytophila, the Agent of Human Granulocytic Ehrlichiosis, in Different Populations in Westchester County, New York. J. Clin. Microbiol.
40: 2612-2615
[Abstract]
[Full Text]
-
Avsic-Zupanc, T., Petrovec, M., Nicholson, W. L., Sumner, J. W., Childs, J. E., Strle, F.
(2001). Clinical and Serological Follow-Up of Patients with Human Granulocytic Ehrlichiosis in Slovenia. CVI
8: 899-903
[Abstract]
[Full Text]
-
Lodes, M. J., Mohamath, R., Reynolds, L. D., McNeill, P., Kolbert, C. P., Bruinsma, E. S., Benson, D. R., Hofmeister, E., Reed, S. G., Houghton, R. L., Persing, D. H.
(2001). Serodiagnosis of Human Granulocytic Ehrlichiosis by Using Novel Combinations of Immunoreactive Recombinant Proteins. J. Clin. Microbiol.
39: 2466-2476
[Abstract]
[Full Text]
-
Brouqui, P., Salvo, E., Dumler, J. S., Raoult, D.
(2001). Diagnosis of Granulocytic Ehrlichiosis in Humans by Immunofluorescence Assay. CVI
8: 199-202
[Abstract]
[Full Text]